Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.38
-0.1200-8.00%
Post-market: 1.400.0200+1.45%19:13 EDT
Volume:717.41K
Turnover:1.03M
Market Cap:99.29M
PE:-0.44
High:1.54
Open:1.47
Low:1.37
Close:1.50
Loading ...
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities